Summit Trail Advisors, LLC Gsk PLC Transaction History

Summit Trail Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	BUY	$38.11 - $42.99 $111,624 - $125,917	2,929 New	2,929 $225,000
Q4 2018 Feb 13, 2019	SELL	$37.8 - $42.69 $139,595 - $157,654	-3,693 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $53,861 - $57,844	-1,355 Reduced 26.84%	3,693 $150,000
Q2 2018 Aug 10, 2018	SELL	$39.61 - $42.76 $409,131 - $441,668	-10,329 Reduced 67.17%	5,048 $206,000
Q1 2018 May 22, 2018	SELL	$36.18 - $40.15 $10.3 Million - $11.4 Million	-284,845 Reduced 94.88%	15,377 $300,000
Q1 2018 May 21, 2018	BUY	$36.18 - $40.15 $10.5 Million - $11.6 Million	289,427 Added 2681.12%	300,222 $300,000
Q4 2017 Feb 14, 2018	BUY	$35.34 - $41.9 $381,495 - $452,310	10,795	10,795 $406,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.